Febuprez Tablet contains Febuxostat 40mg, a potent xanthine oxidase inhibitor used primarily to manage hyperuricemia in patients with gout. By selectively inhibiting the enzyme xanthine oxidase, Febuxostat reduces the production of uric acid, thereby preventing the formation of urate crystals that cause painful gout attacks and joint inflammation. This medication is particularly beneficial for patients who are intolerant to or inadequately managed by other urate-lowering therapies such as allopurinol. Febuprez is indicated for long-term management of chronic gout and is effective in lowering serum uric acid levels to target concentrations. It is important to take Febuprez exactly as prescribed by a healthcare professional, usually once daily, with or without food. Patients should maintain adequate hydration while on this medication to reduce the risk of kidney stones. Common side effects may include nausea, joint pain, and rash, though serious adverse effects are rare. Febuprez should be used cautiously in individuals with liver or kidney impairment and is contraindicated in patients with known hypersensitivity to Febuxostat. Regular monitoring of uric acid levels and liver function tests is recommended during treatment to ensure safety and efficacy. Always consult a healthcare provider before starting or discontinuing Febuprez Tablet.